Loading data for ONC — first visit, this takes a few seconds.
BeOne Medicines AG (ONC)
NasdaqGS: ONC
· Real-Time Price · USD
371.98
-2.49 (-0.66%)
At close: Aug 28, 2026, 8:00 PM
366.73
+0.00%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
BeOne Medicines AG (ONC) Stock Price, Analysis & Data
-0.66% (1D)
No data available
| Bid | 346.74 |
| Market Cap | 41.49B |
| Revenue (ttm) | 6.13B |
| Net Income (ttm) | 655.71M |
| 0.50 | |
| 5.59 | |
| 65.6 | |
| 35.66 | |
| P/B (ttm) | 8.01 |
| P/S (ttm) | 6.77 |
| Earnings Date | Nov 5, 2026 |
| Ask | 360.25 |
| Volume | 349,775 |
| Avg. Volume (20D) | 356,920 |
| Open | 369.77 |
| Previous Close | 374.47 |
| Day's Range | 365.14 - 372.73 |
| 52-Week Range | 253.95 - 385.22 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ONC
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVA...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 3, 2016
Employees 12,000
Stock Exchange NasdaqGS
Ticker Symbol ONC
Website https://beonemedicines.com
Financial Performance
In 2025, BeOne Medicines's revenue was 5.34B, an increase of 40.23% compared to the previous year's 3.81B. Earnings were 286.93M, a decrease of -144.5%.
Financial StatementsEarnings Surprise
BeOne Medicines has released their quarterly earnings on Aug 5, 2026:
- Revenue of $1.71B misses estimates by $0, with 29.63% YoY growth.
- EPS of 2.05 exceeds estimates by 0.42, with 144.05% YoY growth.
BeOne Medicines AG is scheduled to release its earnings on Nov 5, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
